The investment, which marks Fitbit’s first-ever startup investment, is part of a financing round Sano plans to close in the coming months, according to CNBC. Sano’s patch, which the company expects to release in roughly a year, is intended to help people with Type 1 and Type 2 diabetes control their blood glucose levels.
“This [investment] fits into our strategy of looking beyond the device and thinking more about [health] solutions,” Mr. Park told CNBC. “I think the complete solution comes in the form of having some monitoring solution that is coupled with a display, and a wearable that can give you the interventions at the right moment.”
Mr. Park declined to comment on whether future Fitbit wearables would include built-in glucose tracking.
More articles on health IT:
Baptist Health South Florida taps health tech startup for precision cancer care
Kaiser CIO joins Parkland Center for Clinical Innovation’s board of directors: 3 things to know
KLAS: 13 population health management vendors ranked by user satisfaction
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
